Granules India Up 3% After USFDA Inspection Clears Andhra Pradesh Plant – Equitypandit
November 8, 2024November 8, 2024 Shares of Granules India Ltd. rose 3% to a day’s high of Rs 590.50 on 8th November after the company announced that it received an Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its facility in Andhra Pradesh….